News
The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...
Michelle Tarver, of the FDA's Center for Devices and Radiological Health, said: "Today's clearance is an important step for ...
The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and ...
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...
2d
Medical Device Network on MSNFDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’sThe US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...
Fujirebio Diagnostics Inc.’s Alzheimer’s disease assay received the U.S. FDA’s first clearance for a blood test for the ...
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...
The test is for those aged 55 and older who are already exhibiting signs and symptoms of the disease, the FDA says.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results